

Overview
Obesity, characterized by excessive body fat that impairs health, is a major modifiable risk factor in the
development and progression of cardiovascular disease (CVD). Its rising global and regional prevalence has
closely mirrored the growing burden of CVD, making obesity-related cardiovascular disease an increasingly
important focus in clinical practice. Timely intervention of obesity in CVD offers an opportunity not only
to improve cardiovascular outcomes but also to address a wide range of comorbidities linked to excess
weight.
The relationship between increased adiposity and CVD is complex and multifactorial,
involving both direct and indirect mechanisms. Excess fat accumulation contributes to systemic inflammation,
oxidative stress, and insulin resistance. These changes promote atherogenesis, elevate blood pressure,
disrupt lipid metabolism, and lead to structural and functional alterations in the heart, thus influencing
CVD pathophysiology.
Managing obesity involves a comprehensive medical approach focused on
achieving individualized goals for weight reduction and enhanced quality of life. Even modest reductions in
body weight (5 to 10%) can yield substantial weight loss benefits, including improved blood pressure,
glucose control, and lipid levels. Therefore, it is essential for physicians to be familiar with
non-pharmacologic, pharmacologic, and surgical interventions for weight management. Understanding the
specific indications, benefits, and limitations of each option supports personalized, evidence-based care
that enhances weight loss outcomes and reduces cardiovascular risk.
This e-learning module
provides an overview of the relationship between obesity and cardiovascular disease, along with practical
strategies for effective weight management. By outlining the indications for various interventions, it
supports timely, individualized care to improve cardiovascular outcomes and overall health.
Upon completion of this module, learners should be able to:
Dr. Yeo Colin
MBBS (Singapore), FRCP (Edinburgh), DRCPSC
Senior Consultant, Cardiology
Changi General Hospital, Singapore
Keywords: Obesity, cardiovascular disease, obesity-related cardiovascular disease, cardiovascular risk, weight loss benefits, obesity pharmacotherapy